O	0	1	[	[	(	O
O	1	10	Treatment	Treatment	NN	B-NP
O	11	13	of	of	IN	B-PP
B-Pathological_formation	14	22	squamous	squamous	JJ	B-NP
I-Pathological_formation	23	38	intraepithelial	intraepithelial	JJ	I-NP
I-Pathological_formation	39	45	lesion	lesion	NN	I-NP
O	46	48	of	of	IN	B-PP
O	49	53	type	type	NN	B-NP
O	54	58	CIN2	CIN2	NN	I-NP
O	59	61	et	et	NN	I-NP
O	62	66	CIN3	CIN3	NN	I-NP
O	67	71	with	with	IN	B-PP
O	72	77	laser	laser	NN	B-NP
O	78	81	CO2	CO2	NN	I-NP
O	82	94	vaporization	vaporization	NN	I-NP
O	94	95	:	:	:	O
O	96	109	retrospective	retrospective	JJ	B-NP
O	110	115	study	study	NN	I-NP
O	116	118	of	of	IN	B-PP
O	119	121	52	52	CD	B-NP
O	122	127	cases	case	NNS	I-NP
O	127	128	]	]	)	O
O	128	129	.	.	.	O

O	130	140	OBJECTIVES	OBJECTIVES	NNS	B-NP
O	140	141	:	:	:	O

O	142	146	This	This	DT	B-NP
O	147	152	study	study	NN	I-NP
O	153	156	was	be	VBD	B-VP
O	157	164	carried	carry	VBN	I-VP
O	165	168	out	out	RP	B-PRT
O	169	173	over	over	IN	B-PP
O	174	176	an	an	DT	B-NP
O	177	178	8	8	CD	I-NP
O	178	179	-	-	HYPH	I-NP
O	179	183	year	year	NN	I-NP
O	184	190	period	period	NN	I-NP
O	191	193	in	in	IN	B-SBAR
O	194	199	order	order	NN	O
O	200	202	to	to	TO	B-VP
O	203	211	evaluate	evaluate	VB	I-VP
O	212	215	the	the	DT	B-NP
O	216	220	long	long	JJ	I-NP
O	220	221	-	-	HYPH	I-NP
O	221	225	term	term	NN	I-NP
O	226	239	effectiveness	effectiveness	NN	I-NP
O	240	242	of	of	IN	B-PP
O	243	248	laser	laser	NN	B-NP
O	249	252	CO2	CO2	NN	I-NP
O	253	265	vaporization	vaporization	NN	I-NP
O	266	268	in	in	IN	B-PP
O	269	272	the	the	DT	B-NP
O	273	282	treatment	treatment	NN	I-NP
O	283	285	of	of	IN	B-PP
B-Pathological_formation	286	294	squamous	squamous	JJ	B-NP
I-Pathological_formation	295	310	intraepithelial	intraepithelial	JJ	I-NP
I-Pathological_formation	311	317	lesion	lesion	NN	I-NP
O	318	320	of	of	IN	B-PP
O	321	325	type	type	NN	B-NP
O	326	330	CIN2	CIN2	NN	I-NP
O	331	334	and	and	CC	I-NP
O	335	339	CIN3	CIN3	NN	I-NP
O	339	340	.	.	.	O

O	341	350	MATERIALS	MATERIALS	NNS	B-NP
O	351	354	AND	AND	CC	I-NP
O	355	362	METHODS	METHODS	NNS	I-NP
O	362	363	:	:	:	O

O	364	365	A	A	DT	B-NP
O	366	379	retrospective	retrospective	JJ	I-NP
O	380	385	study	study	NN	I-NP
O	386	388	of	of	IN	B-PP
O	389	391	52	52	CD	B-NP
O	392	397	cases	case	NNS	I-NP
O	398	400	of	of	IN	B-PP
B-Pathological_formation	401	409	cervical	cervical	JJ	B-NP
I-Pathological_formation	410	417	lesions	lesion	NNS	I-NP
O	418	420	of	of	IN	B-PP
O	421	425	type	type	NN	B-NP
O	426	430	CIN2	CIN2	NN	I-NP
O	431	434	and	and	CC	I-NP
O	435	439	CIN3	CIN3	NN	I-NP
O	440	447	treated	treat	VBN	B-VP
O	448	450	in	in	IN	B-PP
O	451	456	first	first	JJ	B-NP
O	457	466	intention	intention	NN	I-NP
O	467	469	by	by	IN	B-PP
O	470	475	laser	laser	NN	B-NP
O	476	479	CO2	CO2	NN	I-NP
O	480	492	vaporization	vaporization	NN	I-NP
O	493	496	was	be	VBD	B-VP
O	497	504	carried	carry	VBN	I-VP
O	505	508	out	out	RP	B-PRT
O	509	511	at	at	IN	B-PP
O	512	515	the	the	DT	B-NP
O	516	524	hospital	hospital	NN	I-NP
O	525	531	Jeanne	Jeanne	NNP	I-NP
O	531	532	-	-	HYPH	I-NP
O	532	534	de	de	NNP	I-NP
O	534	535	-	-	HYPH	I-NP
O	535	542	Flandre	Flandre	NNP	I-NP
O	543	545	in	in	IN	B-PP
O	546	550	CHRU	CHRU	NNP	B-NP
O	551	553	of	of	IN	B-PP
O	554	559	Lille	Lille	NNP	B-NP
O	560	564	from	from	IN	B-PP
O	565	569	1996	1996	CD	B-NP
O	570	572	to	to	TO	B-PP
O	573	577	2003	2003	CD	B-NP
O	577	578	.	.	.	O

O	579	583	This	This	DT	B-NP
O	584	593	treatment	treatment	NN	I-NP
O	594	597	was	be	VBD	B-VP
O	598	607	performed	perform	VBN	I-VP
O	608	610	on	on	IN	B-PP
O	611	615	only	only	RB	B-NP
B-Pathological_formation	616	620	high	high	JJ	I-NP
I-Pathological_formation	620	621	-	-	HYPH	I-NP
I-Pathological_formation	621	626	grade	grade	NN	I-NP
I-Pathological_formation	627	630	exo	exo	AFX	O
I-Pathological_formation	630	631	-	-	HYPH	O
I-Pathological_formation	631	639	cervical	cervical	JJ	B-NP
I-Pathological_formation	640	647	lesions	lesion	NNS	I-NP
O	647	648	,	,	,	O
O	649	651	of	of	IN	B-PP
O	652	657	small	small	JJ	B-NP
O	658	662	size	size	NN	I-NP
O	663	664	(	(	(	O
O	664	665	<	<	SYM	B-NP
O	665	669	2cm2	2cm2	CD	I-NP
O	669	670	)	)	)	O
O	670	671	,	,	,	O
O	672	677	after	after	IN	B-PP
O	678	679	a	a	DT	B-NP
O	680	688	complete	complete	JJ	I-NP
O	689	700	colposcopic	colposcopic	JJ	I-NP
O	701	712	examination	examination	NN	I-NP
O	712	713	.	.	.	O

O	714	721	RESULTS	RESULTS	NNS	B-NP
O	721	722	:	:	:	O

O	723	728	Fifty	Fifty	CD	B-NP
O	728	729	-	-	HYPH	I-NP
O	729	732	two	two	CD	B-NP
O	733	741	patients	patient	NNS	I-NP
O	742	746	were	be	VBD	B-VP
O	747	754	treated	treat	VBN	I-VP
O	755	757	by	by	IN	B-PP
O	758	763	first	first	JJ	B-NP
O	763	764	-	-	HYPH	I-NP
O	764	773	intention	intention	NN	I-NP
O	774	779	laser	laser	NN	I-NP
O	780	792	vaporization	vaporization	NN	I-NP
O	793	797	only	only	RB	B-ADVP
O	797	798	.	.	.	O

O	799	803	Mean	Mean	JJ	B-NP
O	804	807	age	age	NN	I-NP
O	808	811	was	be	VBD	B-VP
O	812	814	29	29	CD	B-NP
O	814	815	.	.	.	O
O	815	816	4	4	CD	B-NP
O	817	822	years	year	NNS	I-NP
O	823	826	and	and	CC	O
O	827	829	51	51	CD	B-NP
O	829	830	.	.	.	O
O	830	831	9	9	CD	B-NP
O	831	832	%	%	NN	I-NP
O	833	837	were	be	VBD	B-VP
O	838	849	nulliparous	nulliparous	JJ	B-ADJP
O	849	850	.	.	.	O

O	851	853	At	At	IN	B-PP
O	854	857	the	the	DT	B-NP
O	858	863	first	first	JJ	I-NP
O	864	868	cyto	cyto	AFX	I-NP
O	868	869	-	-	HYPH	I-NP
O	869	880	colposcopic	colposcopic	JJ	B-NP
O	881	888	control	control	NN	I-NP
O	888	889	,	,	,	O
O	890	895	there	there	EX	B-NP
O	896	900	were	be	VBD	B-VP
O	901	903	17	17	CD	B-NP
O	904	914	persistent	persistent	JJ	I-NP
B-Pathological_formation	915	922	lesions	lesion	NNS	I-NP
O	923	924	(	(	(	O
O	924	926	32	32	CD	B-NP
O	926	927	.	.	.	O
O	927	928	7	7	CD	B-NP
O	928	929	%	%	NN	I-NP
O	929	930	)	)	)	O
O	930	931	.	.	.	O

O	932	937	Among	Among	IN	B-PP
O	938	941	the	the	DT	B-NP
O	942	944	35	35	CD	I-NP
O	945	953	patients	patient	NNS	I-NP
O	954	961	without	without	IN	B-PP
O	962	972	persistent	persistent	JJ	B-NP
B-Pathological_formation	973	979	lesion	lesion	NN	I-NP
O	979	980	,	,	,	O
O	981	983	29	29	CD	B-NP
O	984	992	achieved	achieve	VBD	B-VP
O	993	997	cure	cure	NN	B-NP
O	998	999	(	(	(	O
O	999	1006	absence	absence	NN	B-NP
O	1007	1009	of	of	IN	B-PP
O	1010	1020	recurrence	recurrence	NN	B-NP
O	1020	1021	)	)	)	O
O	1021	1022	,	,	,	O
O	1023	1024	4	4	CD	B-NP
O	1025	1034	presented	present	VBD	B-VP
O	1035	1036	a	a	DT	B-NP
O	1037	1047	recurrence	recurrence	NN	I-NP
O	1048	1051	and	and	CC	I-NP
O	1052	1053	2	2	CD	I-NP
O	1054	1058	were	be	VBD	B-VP
O	1059	1063	lost	lose	VBN	I-VP
O	1064	1066	to	to	TO	I-VP
O	1067	1073	follow	follow	VB	I-VP
O	1073	1074	-	-	HYPH	B-PRT
O	1074	1076	up	up	RP	B-PRT
O	1076	1077	.	.	.	O

O	1078	1088	CONCLUSION	CONCLUSION	NN	B-NP
O	1088	1089	:	:	:	O

O	1090	1093	The	The	DT	B-NP
O	1094	1101	current	current	JJ	I-NP
O	1102	1106	data	datum	NNS	I-NP
O	1107	1109	of	of	IN	B-PP
O	1110	1113	the	the	DT	B-NP
O	1114	1124	literature	literature	NN	I-NP
O	1125	1135	concerning	concern	VBG	B-VP
O	1136	1139	the	the	DT	B-NP
O	1140	1149	treatment	treatment	NN	I-NP
O	1150	1152	by	by	IN	B-PP
O	1153	1158	laser	laser	NN	B-NP
O	1159	1162	CO2	CO2	NN	I-NP
O	1163	1175	vaporization	vaporization	NN	I-NP
O	1176	1185	authorize	authorize	VBP	B-VP
O	1186	1197	application	application	NN	B-NP
O	1198	1200	of	of	IN	B-PP
O	1201	1205	this	this	DT	B-NP
O	1206	1212	method	method	NN	I-NP
O	1213	1216	for	for	IN	B-PP
O	1217	1224	certain	certain	JJ	B-NP
B-Pathological_formation	1225	1229	high	high	JJ	I-NP
I-Pathological_formation	1229	1230	-	-	HYPH	I-NP
I-Pathological_formation	1230	1235	grade	grade	NN	I-NP
I-Pathological_formation	1236	1247	exocervical	exocervical	JJ	I-NP
I-Pathological_formation	1248	1255	lesions	lesion	NNS	I-NP
O	1256	1261	after	after	IN	B-PP
O	1262	1263	a	a	DT	B-NP
O	1264	1272	complete	complete	JJ	I-NP
O	1273	1284	colposcopic	colposcopic	JJ	I-NP
O	1285	1296	examination	examination	NN	I-NP
O	1296	1297	.	.	.	O

O	1298	1302	This	This	DT	B-NP
O	1303	1307	type	type	NN	I-NP
O	1308	1310	of	of	IN	B-PP
O	1311	1320	treatment	treatment	NN	B-NP
O	1321	1328	remains	remain	VBZ	B-VP
O	1329	1333	less	less	RBR	B-ADJP
O	1334	1344	aggressive	aggressive	JJ	I-ADJP
O	1345	1349	than	than	IN	B-PP
O	1350	1351	a	a	DT	B-NP
O	1352	1360	surgical	surgical	JJ	I-NP
O	1361	1370	treatment	treatment	NN	I-NP
O	1370	1371	.	.	.	O

O	1372	1375	The	The	DT	B-NP
O	1376	1380	high	high	JJ	I-NP
O	1381	1385	rate	rate	NN	I-NP
O	1386	1388	of	of	IN	B-PP
O	1389	1397	residual	residual	JJ	B-NP
B-Pathological_formation	1398	1405	lesions	lesion	NNS	I-NP
O	1406	1408	in	in	IN	B-PP
O	1409	1419	particular	particular	JJ	B-NP
O	1420	1422	in	in	IN	B-PP
O	1423	1426	the	the	DT	B-NP
O	1427	1432	event	event	NN	I-NP
O	1433	1435	of	of	IN	B-PP
O	1436	1440	CIN3	CIN3	NN	B-NP
O	1441	1444	can	can	MD	B-VP
O	1445	1447	be	be	VB	I-VP
O	1448	1451	due	due	JJ	B-ADVP
O	1452	1454	to	to	TO	B-PP
O	1455	1457	an	an	DT	B-NP
O	1458	1468	incomplete	incomplete	JJ	I-NP
O	1469	1480	destruction	destruction	NN	I-NP
O	1481	1483	of	of	IN	B-PP
O	1484	1487	the	the	DT	B-NP
B-Pathological_formation	1488	1494	lesion	lesion	NN	I-NP
O	1494	1495	.	.	.	O

O	1496	1504	Patients	Patient	NNS	B-NP
O	1505	1511	should	should	MD	B-VP
O	1512	1516	thus	thus	RB	I-VP
O	1517	1519	be	be	VB	I-VP
O	1520	1527	advised	advise	VBN	I-VP
O	1528	1532	that	that	IN	B-SBAR
O	1533	1543	monitoring	monitoring	NN	B-NP
O	1544	1546	is	be	VBZ	B-VP
O	1547	1549	an	an	DT	B-NP
O	1550	1558	integral	integral	JJ	I-NP
O	1559	1563	part	part	NN	I-NP
O	1564	1566	of	of	IN	B-PP
O	1567	1570	the	the	DT	B-NP
O	1571	1580	treatment	treatment	NN	I-NP
O	1580	1581	.	.	.	O

O	1582	1587	Laser	Laser	NN	B-NP
O	1588	1600	vaporization	vaporization	NN	I-NP
O	1601	1606	could	could	MD	B-VP
O	1607	1609	be	be	VB	I-VP
O	1610	1617	limited	limit	VBN	I-VP
O	1618	1620	to	to	TO	B-PP
O	1621	1625	CIN1	CIN1	NN	B-NP
O	1626	1629	and	and	CC	I-NP
O	1630	1634	CIN2	CIN2	NN	I-NP
B-Pathological_formation	1635	1642	lesions	lesion	NNS	I-NP
O	1642	1643	.	.	.	O

